Security News Highlights 07/14/2014

By | |
Share This:(PGNX) (KNDI) (URS) Higher; (HLIT) (RVBD) (GTAT) Lower (more…) 9:33 AM ET, 07/14/2014 – Street Insider Progenics Pharmaceuticals (Nasdaq: PGNX) 14.2% HIGHER; Salix Pharmaceuticals, Ltd. (Nasaq: SLXP) and Progenics Pharmaceuticals (Nasdaq: PGNX) announced that the Food and Drug Administration (FDA or Agency) has informed Salix that RELISTOR (methylnaltrexone bromide) Subcutaneous Injection, 20 mg/ml, for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain can be approved on the data submitted in the sNDA. The FDA Office of Drug Evaluation III responded to the Companys formal appeal filed in response to the Complete Response Letter

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
Forgot password? Click here to reset
New User Registration

*Required field
Bookmark the permalink.

About securitytradeideas

Our mission at Security Trade Ideas (STI) is to provide our readers with profitable Security Trade Ideas and to gain their trust by providing reliable and trustworthy financial information. We want to save you research time and money to enable you to manage your own portfolio. Our passion is to research and to find Security Trade Ideas. We would like to help our readers prosper.

Comments are closed.